Tracing Changed Production of Red Blood Cells

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions

ErythrocytosisErythropoiesis Abnormal

Interventions

DRUG

Recombinant human erythropoietin

Recombinant human erythropoietin treatment three times per week for three weeks

Trial Locations (1)

Department of Nutrition, Exercise and Sports, Copenhagen

All Listed Sponsors

lead

University of Copenhagen

OTHER